THE BLOG

Expert views on Analgesic News

mark field

Approval of new pain drug shows the path for analgesic innovation

The new Novartis medicine Adakveo® (crizanlizumab)has just been approved by the FDA to reduce frequency of pain crises in individuals...

mark field

Patient-Inspired R&D – the missing part of patient engagement

Patient engagement is the ‘hot topic’ within the pharma industry over the last few years, with every company, Biotech, CRO and consultant...